Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
S6K1- and ßTRCP-Mediated Degradation of PDCD4 Promotes Protein Translation and Cell Growth
N. Valerio Dorrello,1*Angelo Peschiaroli,1*Daniele Guardavaccaro,1Nancy H. Colburn,2Nicholas E. Sherman,3Michele Pagano1
The tumor suppressor programmed cell death protein 4 (PDCD4)inhibits the translation initiation factor eIF4A, an RNA helicasethat catalyzes the unwinding of secondary structure at the 5'untranslated region (5'UTR) of messenger RNAs (mRNAs). In responseto mitogens, PDCD4 was rapidly phosphorylated on Ser67 by theprotein kinase S6K1 and subsequently degraded via the ubiquitinligase SCFßTRCP. Expression in cultured cells of astable PDCD4 mutant that is unable to bind ßTRCP inhibitedtranslation of an mRNA with a structured 5'UTR, resulted insmaller cell size, and slowed down cell cycle progression. Wepropose that regulated degradation of PDCD4 in response to mitogensallows efficient protein synthesis and consequently cell growth.
1 Department of Pathology, NYU Cancer Institute, New York University School of Medicine, 550 First Avenue, MSB 599, New York, NY 10016, USA. 2 Laboratory of Cancer Prevention, National Cancer Institute, Building 576, Frederick, MD 21702, USA. 3 W. M. Keck Biomedical Mass Spectrometry Lab, University of Virginia, Charlottesville, VA 22908, USA.
* These authors contributed equally to this work.
To whom correspondence should be addressed. E-mail: michele.pagano{at}med.nyu.edu
The editors suggest the following Related Resources on Science sites:
In Science Magazine
PERSPECTIVES
Nahum Sonenberg and Arnim Pause (20 October 2006) Science314 (5798), 428.
[DOI: 10.1126/science.1134031] |Summary »|Full Text »|PDF »
In Science Signaling
EDITORS' CHOICE
L. Bryan Ray (24 October 2006) Sci. STKE2006 (358), tw362.
[DOI: 10.1126/stke.3582006tw362] |Abstract »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Tumorigenic activity and therapeutic inhibition of Rheb GTPase.
K. J. Mavrakis, H. Zhu, R. L.A. Silva, J. R. Mills, J. Teruya-Feldstein, S. W. Lowe, W. Tam, J. Pelletier, and H.-G. Wendel (2008)
Genes & Dev.
22, 2178-2188
|Abstract »|Full Text »|PDF »
mTORC1 promotes survival through translational control of Mcl-1.
J. R. Mills, Y. Hippo, F. Robert, S. M. H. Chen, A. Malina, C.-J. Lin, U. Trojahn, H.-G. Wendel, A. Charest, R. T. Bronson, et al. (2008)
PNAS
105, 10853-10858
|Abstract »|Full Text »|PDF »
Statin-Dependent Suppression of the Akt/Mammalian Target of Rapamycin Signaling Cascade and Programmed Cell Death 4 Up-Regulation in Renal Cell Carcinoma.
J. Woodard, A. Sassano, N. Hay, and L. C. Platanias (2008)
Clin. Cancer Res.
14, 4640-4649
|Abstract »|Full Text »|PDF »
c-Myc and eIF4F Are Components of a Feedforward Loop that Links Transcription and Translation.
C.-J. Lin, R. Cencic, J. R. Mills, F. Robert, and J. Pelletier (2008)
Cancer Res.
68, 5326-5334
|Abstract »|Full Text »|PDF »
Rac1 accumulates in the nucleus during the G2 phase of the cell cycle and promotes cell division.
D. Michaelson, W. Abidi, D. Guardavaccaro, M. Zhou, I. Ahearn, M. Pagano, and M. R. Philips (2008)
J. Cell Biol.
181, 485-496
|Abstract »|Full Text »|PDF »
Suppression of Programmed Cell Death 4 (PDCD4) Protein Expression by BCR-ABL-regulated Engagement of the mTOR/p70 S6 Kinase Pathway.
N. Carayol, E. Katsoulidis, A. Sassano, J. K. Altman, B. J. Druker, and L. C. Platanias (2008)
J. Biol. Chem.
283, 8601-8610
|Abstract »|Full Text »|PDF »
PDCD4 inhibits translation initiation by binding to eIF4A using both its MA3 domains.
C. Suzuki, R. G. Garces, K. A. Edmonds, S. Hiller, S. G. Hyberts, A. Marintchev, and G. Wagner (2008)
PNAS
105, 3274-3279
|Abstract »|Full Text »|PDF »
Translation Inhibitor Pdcd4 Is Targeted for Degradation during Tumor Promotion.
T. Schmid, A. P. Jansen, A. R. Baker, G. Hegamyer, J. P. Hagan, and N. H. Colburn (2008)
Cancer Res.
68, 1254-1260
|Abstract »|Full Text »|PDF »
Regulatory Effects of Mammalian Target of Rapamycin-mediated Signals in the Generation of Arsenic Trioxide Responses.
J. K. Altman, P. Yoon, E. Katsoulidis, B. Kroczynska, A. Sassano, A. J. Redig, H. Glaser, A. Jordan, M. S. Tallman, N. Hay, et al. (2008)
J. Biol. Chem.
283, 1992-2001
|Abstract »|Full Text »|PDF »
Programmed Cell Death 4 (PDCD4) Is an Important Functional Target of the MicroRNA miR-21 in Breast Cancer Cells.
L. B. Frankel, N. R. Christoffersen, A. Jacobsen, M. Lindow, A. Krogh, and A. H. Lund (2008)
J. Biol. Chem.
283, 1026-1033
|Abstract »|Full Text »|PDF »
Removal of S6K1 and S6K2 leads to divergent alterations in learning, memory, and synaptic plasticity.
M. D. Antion, M. Merhav, C. A. Hoeffer, G. Reis, S. C. Kozma, G. Thomas, E. M. Schuman, K. Rosenblum, and E. Klann (2008)
Learn. Mem.
15, 29-38
|Abstract »|Full Text »|PDF »
FoxO transcription factors activate Akt and attenuate insulin signaling in heart by inhibiting protein phosphatases.
Y. G. Ni, N. Wang, D. J. Cao, N. Sachan, D. J. Morris, R. D. Gerard, M. Kuro-o, B. A. Rothermel, and J. A. Hill (2007)
PNAS
104, 20517-20522
|Abstract »|Full Text »|PDF »
A Novel Function of eIF2{alpha} Kinases as Inducers of the Phosphoinositide-3 Kinase Signaling Pathway.
S. Kazemi, Z. Mounir, D. Baltzis, J. F. Raven, S. Wang, J.-L. Krishnamoorthy, O. Pluquet, J. Pelletier, and A. E. Koromilas (2007)
Mol. Biol. Cell
18, 3635-3644
|Abstract »|Full Text »|PDF »
SCFFbxl3 Controls the Oscillation of the Circadian Clock by Directing the Degradation of Cryptochrome Proteins.
L. Busino, F. Bassermann, A. Maiolica, C. Lee, P. M. Nolan, S. I. H. Godinho, G. F. Draetta, and M. Pagano (2007)
Science
316, 900-904
|Abstract »|Full Text »|PDF »
Exploring Translation Initiation as a Chemotherapeutic Target.
J. Pelletier (2007)
Am. Assoc. Cancer Res. Educ. Book
2007, 147-152
|Full Text »|PDF »
Nuclear Factor-{kappa}B Accounts for the Repressor Effects of High Stromal Cell-Derived Factor-1{alpha} Levels on Tac1 Expression in Nontumorigenic Breast Cells.